![]() |
Name |
2-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)ethanone
|
Molecular Formula | C9H10O4 | |
IUPAC Name* |
2-hydroxy-1-(4-hydroxy-3-methoxyphenyl)ethanone
|
|
SMILES |
COC1=C(C=CC(=C1)C(=O)CO)O
|
|
InChI |
InChI=1S/C9H10O4/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,10-11H,5H2,1H3
|
|
InChIKey |
QNMANLUEFQNQCX-UHFFFAOYSA-N
|
|
Synonyms |
2-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)ethanone; 2,4'-Dihydroxy-3'-methoxyacetophenone; 18256-48-9; Acetophenone, 2,4'-dihydroxy-3'-methoxy-; alpha-Hydroxyacetovanillone; Ethanone, 2-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-; alpha-Hydroxyacetoguaiacone; alpha,4-Dihydroxy-3-methoxyacetophenone; BRN 2259722; NSC526464; 4-08-00-02739 (Beilstein Handbook Reference); CHEMBL592620; SCHEMBL1491848; DTXSID00171305; ZINC394315; Phenol, 4-hydroxyacetyl-2-methoxy-; NSC 526464; NSC-526464; 2-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)ethanone #
|
|
CAS | 18256-48-9 | |
PubChem CID | 87530 | |
ChEMBL ID | CHEMBL592620 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 182.17 | ALogp: | -0.1 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 66.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.683 |
Caco-2 Permeability: | -4.566 | MDCK Permeability: | 0.00001240 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.019 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.329 |
Blood-Brain-Barrier Penetration (BBB): | 0.796 | Plasma Protein Binding (PPB): | 36.31% |
Volume Distribution (VD): | 0.927 | Fu: | 58.57% |
CYP1A2-inhibitor: | 0.464 | CYP1A2-substrate: | 0.607 |
CYP2C19-inhibitor: | 0.039 | CYP2C19-substrate: | 0.158 |
CYP2C9-inhibitor: | 0.017 | CYP2C9-substrate: | 0.567 |
CYP2D6-inhibitor: | 0.027 | CYP2D6-substrate: | 0.43 |
CYP3A4-inhibitor: | 0.026 | CYP3A4-substrate: | 0.224 |
Clearance (CL): | 9.106 | Half-life (T1/2): | 0.919 |
hERG Blockers: | 0.047 | Human Hepatotoxicity (H-HT): | 0.023 |
Drug-inuced Liver Injury (DILI): | 0.417 | AMES Toxicity: | 0.418 |
Rat Oral Acute Toxicity: | 0.422 | Maximum Recommended Daily Dose: | 0.022 |
Skin Sensitization: | 0.284 | Carcinogencity: | 0.076 |
Eye Corrosion: | 0.464 | Eye Irritation: | 0.99 |
Respiratory Toxicity: | 0.541 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000296 | ![]() |
0.718 | D0E9CD | ![]() |
0.413 | ||
ENC001056 | ![]() |
0.675 | D0U0OT | ![]() |
0.389 | ||
ENC000507 | ![]() |
0.545 | D0C4YC | ![]() |
0.362 | ||
ENC000325 | ![]() |
0.531 | D0U5CE | ![]() |
0.352 | ||
ENC004349 | ![]() |
0.529 | D03LGG | ![]() |
0.352 | ||
ENC001055 | ![]() |
0.523 | D0BA6T | ![]() |
0.345 | ||
ENC001101 | ![]() |
0.521 | D08HVR | ![]() |
0.333 | ||
ENC000172 | ![]() |
0.512 | D01WJL | ![]() |
0.333 | ||
ENC000068 | ![]() |
0.512 | D0Y6KO | ![]() |
0.328 | ||
ENC000499 | ![]() |
0.490 | D0P7JZ | ![]() |
0.328 |